Ranjana is a Senior Analyst at the Global Strategy Lab.
She’s a seasoned interdisciplinary health policy researcher with professional experiences across academic research groups, biopharmaceutical companies, and consulting. She holds an MSc in International Health Policy from the London School of Economics and Political Science (LSE), where she completed her thesis on the real-world outcomes achieved by chimeric antigen T-cell receptor therapies (novel cancer treatment). With her passion to apply rigorous research methods for health policy decision-making, she held several research roles at GSL, contributing to a wide array of research projects. Currently, she is supporting the Lab’s organizational strategy and operations.